Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by ...

“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degenerati ... leaders MALVERN, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE ...

This is the first registrational clinical trial of AXPAXLI in wet age-related macular degeneration ... are now expected in Q4 2025 BEDFORD, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Ocular ...

Examining the performance of AI algorithms versus human graders in neovascular age-related macular degeneration ...

Company confirms topline results for COAST anticipated in early 2Q CY25 ...

Ophthalmologists must take measures to avoid misdiagnosing age-related macular degeneration and consider mimics of the ...

Age-related macular degeneration (AMD) is a progressive eye condition that primarily affects people over the age of 50. AMD is a leading cause of vision loss in people over 50.

Wet age-related macular degeneration threatens central vision when abnormal blood vessels leak fluid in the eye. Treatments can help preserve eyesight but may cost tens of thousands per year.

Several clinical trials are being conducted to evaluate additional novel agents to treat age-related macular degeneration.

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

Jan. 16, 2025 — A new report shows the benefit of wearing contact lenses for slowing myopia has a lasting effect -- good news since 50% of the world (5 billion people) will likely be nearsighted ...